- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Diffuse Large B-Cell Lymphoma, Not Otherwise Specified in China
Total 483 results
-
Hutchison Medipharma LimitedUnknownMature B-cell NeoplasmsChina
-
Innovent Biologics (Suzhou) Co. Ltd.CompletedIndolent Non-hodgkin LymphomaChina
-
Innovative Cellular Therapeutics Co., Ltd.UnknownLymphoma, B-Cell | Leukemia, B-CellChina
-
Beijing InnoCare Pharma Tech Co., Ltd.Active, not recruitingB-cell Lymphoma Refractory | B-cell Lymphoma RecurrentChina
-
Bioray LaboratoriesFirst Affiliated Hospital of Zhejiang UniversityCompleted
-
Second Affiliated Hospital of Xi'an Jiaotong UniversityNanjing Legend Biotech Co.Terminated
-
Beijing InnoCare Pharma Tech Co., Ltd.Active, not recruiting
-
Kite, A Gilead CompanyAvailableFollicular Lymphoma | Large B-cell LymphomaUnited States, Japan
-
Kecellitics Biotech Company LtdHebei Yanda Ludaopei HospitalNot yet recruiting
-
First Affiliated Hospital of Zhejiang UniversityHangzhou HeZheng Pharmaceutical Co., LtdUnknown
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruitingMature B Cell NeoplasmsChina
-
Shanxi Province Cancer HospitalNovatim Immune Therapeutics (Zhejiang) Co., Ltd.Recruiting
-
Chinese PLA General HospitalUnknownLymphoma, B-CellChina
-
Dizal PharmaceuticalsRecruitingLymphoma, Non-HodgkinChina
-
Peking Union Medical College HospitalRecruiting
-
Kyowa Kirin Co., Ltd.Active, not recruitingStudy of ME-401 in Subjects With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma (NHL)Indolent B-cell Non-Hodgkin's LymphomaJapan
-
Regeneron PharmaceuticalsRecruitingB-cell Non-Hodgkin Lymphoma (NHL)United States, Korea, Republic of, China, Spain, Japan, United Kingdom, France, Taiwan, Singapore, Italy, Australia, Canada, Germany, Poland
-
The First Affiliated Hospital with Nanjing Medical...RecruitingPTCL, NOS | AITL | ALK- ALCL | Phase III-IV ALK+ ALCL | EATLChina
-
SymBio PharmaceuticalsCompletedNon-Hodgkin's Lymphoma | Mantle Cell LymphomaJapan
-
Second Affiliated Hospital, School of Medicine,...Hangzhou Rongu Biotechnology Co., Ltd.RecruitingRelapsed or Refractory B-cell LymphomaChina
-
Henan Cancer HospitalRecruitingMarginal Zone LymphomaChina
-
Eisai Co., Ltd.CompletedRelapsed or Refractory B-cell Non-Hodgkin's LymphomaJapan
-
Peking University Cancer Hospital & InstituteShanghai Ming Ju Biotechnology Co., Ltd.RecruitingB-cell LymphomaChina
-
He HuangRecruitingAIDS Related Lymphoma and LympholeukemiaChina
-
YuLiUnknownLymphoma, B-Cell | Refractory Lymphoma | Relapse/Recurrence | Dual-target CAR-T CellsChina
-
Qingdao Central HospitalYake Biotechnology Ltd.UnknownLymphoma, B-Cell | Leukemia, B-Cell | Minimal Disease, ResidualChina
-
Institute of Hematology & Blood Diseases HospitalRecruitingMarginal Zone LymphomaChina
-
Hebei Senlang Biotechnology Inc., Ltd.Cangzhou People's HospitalRecruitingLymphoma, B-Cell | Multiple Myeloma | Leukemia, T-Cell | Leukemia, B-cellChina
-
Wuhan Union Hospital, ChinaShanghai Simnova Biotechnology Co.,Ltd.RecruitingChronic Lymphocytic Leukemia | Acute Lymphocytic Leukemia | Non Hodgkin's LymphomaChina
-
Beijing Mabworks Biotech Co., Ltd.RecruitingFollicular Lymphoma and Marginal Zone LymphomaChina
-
The First Affiliated Hospital of Xiamen UniversityFujian Cancer Hospital; Chinese PLA General Hospital; Jiangxi Provincial Cancer... and other collaboratorsRecruiting
-
Beijing Boren HospitalRecruitingChronic Lymphocytic Leukemia | Non Hodgkin Lymphoma | Acute Lymphocytic LeukemiaChina
-
Beijing Mabworks Biotech Co., Ltd.RecruitingFollicular Lymphoma and Marginal Zone LymphomaChina
-
GenmabAbbVieActive, not recruiting
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.TerminatedRelapsed or Refractory Primary Mediastinal B-cell Lymphoma (rrPMBCL)China
-
AstraZenecaActive, not recruitingPhase I: Relapsed or Refractory B-cell Malignancies | Phase II Cohort A: Relapsed or Refractory Mantle Cell Lymphoma | Phase II Cohort B: Relapsed or Refractory Chronic Lymphocytic LeukemiaChina
-
Nanjing Sanhome Pharmaceutical, Co., Ltd.UnknownFollicular Lymphoma(FL) | Marginal Zone Lymphoma(MZL)China
-
Innovent Biologics (Suzhou) Co. Ltd.Completed
-
Lixia ShengRecruitingOR Regimen for Relapsed/Refractory Marginal Zone LymphomaChina
-
BayerCompletedLymphoma, B-Cell | Non-Hodgkin's Lymphoma | Lymphoma, Low-GradeJapan
-
Ascentage Pharma Group Inc.Suzhou Yasheng Pharmaceutical Co., Ltd.Active, not recruitingChronic Lymphocytic Leukemia | Non Hodgkin LymphomaChina
-
PersonGen BioTherapeutics (Suzhou) Co., Ltd.Second Affiliated Hospital of Suzhou UniversityUnknownFollicular Lymphoma | Mantle Cell Lymphoma | B Acute Lymphoblastic LeukemiaChina
-
Sun Yat-sen UniversityRecruitingResolved Hepatitis B | CD20 Positive B-cell LymphomaChina
-
International Extranodal Lymphoma Study Group (IELSG)Active, not recruitingPrimary Mediastinal B-cell LymphomaNorway, United Kingdom, Italy, Switzerland, Czechia, United States, China, Argentina, Canada, Germany, Poland, Portugal, Sweden, Ukraine
-
Merck Sharp & Dohme LLCActive, not recruitingMature B-cell NeoplasmsJapan
-
Kite, A Gilead CompanyRecruitingRelapsed/Refractory Mantle Cell Lymphoma | Relapsed/Refractory B-precursor Acute Lymphoblastic LeukemiaJapan
-
Beijing InnoCare Pharma Tech Co., Ltd.RecruitingRelapsed/Refractory Marginal Zone LymphomaChina
-
Eureka Therapeutics Inc.Peking UniversityCompleted
-
Beijing Biohealthcare Biotechnology Co.,LtdUnknown